Trade LUCD anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Lucid Diagnostics Inc. (LUCD) is trading at US$0.98, down 0.30% today as of Aug 28, 13:04 EDT. The company has a market capitalisation of US$184.13M. Over the past 52 weeks, LUCD has traded between US$0.86 and US$1.63. On Syfe you can trade LUCD with $0 commission and add it to your watchlist.
| Previous close | US$0.98 |
|---|---|
| Market cap | US$184.13M |
| 52-week range | US$0.86 – US$1.63 |
| Volume | 962.67K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Lucid Diagnostics Inc.
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.
Year: 2021
Lucid Diagnostics Completes $18 Million Direct Offering of Shares
Apr 24, 4:28 PM · MT Newswires
Lucid Diagnostics Prices Registered Direct Offering of 18 Million Shares
Apr 23, 1:49 PM · MT Newswires
Lucid Diagnostics Inc. (LUCD) stock is trading at US$0.98, -0.30% from the previous close of US$0.98.
The market cap for Lucid Diagnostics Inc. (LUCD) stock is approximately US$184.13M.
The 52-week high for Lucid Diagnostics Inc. (LUCD) stock is US$1.63.
The 52-week low for Lucid Diagnostics Inc. (LUCD) stock is US$0.86.
Lucid Diagnostics Inc. (LUCD) does not currently pay a dividend.
Stay on top of LUCD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
